Effectiveness of penfluridol (oral long acting neuroleptic) as compared to second generation oral neuroleptics in psychotic disorder patients: an open label randomized controlled trial.

Registry ID

EUCTR2014-003834-21

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE3

Sponsor

Erasmus Medical Center Rotterdam

Start date

2015-04-01

Last update

2026-08-16

Conditions

• Psychotic disorders

Summary

The primary objective of this study is to determine the time to all-cause medication discontinuation of penfluridol (acemap; oral long acting neuroleptic) as compared to second-generation oral neuroleptics (olanzapine, risperidone) using an open label randomized controlled trial design in 180 patients.

Locations

• , , Netherlands

View on source registry